Immunotherapy targeted at brain cancer stem cells

Research output: Contribution to journalArticle

Abstract

Progress in stem cell research has been associated with the discovery of the presence of cancer stem cells in a variety of malignant tumors, and because these cells are resistant to anticancer agents and radiotherapy, analysis of their properties has been rapidly pursued as an important target for the treatment of cancers, including malignant brain tumors. Brain cancer stem cells (BCSCs) have been isolated from brain tumor tissue and brain tumor cell lines by using neural stem cell culture methods. Analyzing the properties of BCSCs is extremely important to developing treatment methods that target BCSCs. Although no treatment method targeting BCSCs has yet been established, several methods have been proposed based on their cell-biological characteristics. This article describes therapeutic strategies that target drug-resistance molecules and stem-cell-associated molecules as well as immunotherapy targeted at BCSCs.

Original languageEnglish
Pages (from-to)48-50
Number of pages3
JournalOpen Cancer Immunology Journal
Volume3
Publication statusPublished - 2010

Fingerprint

Neoplastic Stem Cells
Brain Neoplasms
Immunotherapy
Brain Stem
Stem Cell Research
Neural Stem Cells
Therapeutics
Tumor Cell Line
Drug Resistance
Antineoplastic Agents
Neoplasms
Radiotherapy
Stem Cells
Cell Culture Techniques

Keywords

  • Cancer stem cell
  • Glioma
  • Immunotherapy
  • Vaccine

ASJC Scopus subject areas

  • Cancer Research
  • Immunology
  • Oncology

Cite this

Immunotherapy targeted at brain cancer stem cells. / Toda, Masahiro.

In: Open Cancer Immunology Journal, Vol. 3, 2010, p. 48-50.

Research output: Contribution to journalArticle

@article{e7156248a0bf499bb6d75314d432adb0,
title = "Immunotherapy targeted at brain cancer stem cells",
abstract = "Progress in stem cell research has been associated with the discovery of the presence of cancer stem cells in a variety of malignant tumors, and because these cells are resistant to anticancer agents and radiotherapy, analysis of their properties has been rapidly pursued as an important target for the treatment of cancers, including malignant brain tumors. Brain cancer stem cells (BCSCs) have been isolated from brain tumor tissue and brain tumor cell lines by using neural stem cell culture methods. Analyzing the properties of BCSCs is extremely important to developing treatment methods that target BCSCs. Although no treatment method targeting BCSCs has yet been established, several methods have been proposed based on their cell-biological characteristics. This article describes therapeutic strategies that target drug-resistance molecules and stem-cell-associated molecules as well as immunotherapy targeted at BCSCs.",
keywords = "Cancer stem cell, Glioma, Immunotherapy, Vaccine",
author = "Masahiro Toda",
year = "2010",
language = "English",
volume = "3",
pages = "48--50",
journal = "Open Cancer Immunology Journal",
issn = "1876-4010",
publisher = "Bentham Science Publishers B.V.",

}

TY - JOUR

T1 - Immunotherapy targeted at brain cancer stem cells

AU - Toda, Masahiro

PY - 2010

Y1 - 2010

N2 - Progress in stem cell research has been associated with the discovery of the presence of cancer stem cells in a variety of malignant tumors, and because these cells are resistant to anticancer agents and radiotherapy, analysis of their properties has been rapidly pursued as an important target for the treatment of cancers, including malignant brain tumors. Brain cancer stem cells (BCSCs) have been isolated from brain tumor tissue and brain tumor cell lines by using neural stem cell culture methods. Analyzing the properties of BCSCs is extremely important to developing treatment methods that target BCSCs. Although no treatment method targeting BCSCs has yet been established, several methods have been proposed based on their cell-biological characteristics. This article describes therapeutic strategies that target drug-resistance molecules and stem-cell-associated molecules as well as immunotherapy targeted at BCSCs.

AB - Progress in stem cell research has been associated with the discovery of the presence of cancer stem cells in a variety of malignant tumors, and because these cells are resistant to anticancer agents and radiotherapy, analysis of their properties has been rapidly pursued as an important target for the treatment of cancers, including malignant brain tumors. Brain cancer stem cells (BCSCs) have been isolated from brain tumor tissue and brain tumor cell lines by using neural stem cell culture methods. Analyzing the properties of BCSCs is extremely important to developing treatment methods that target BCSCs. Although no treatment method targeting BCSCs has yet been established, several methods have been proposed based on their cell-biological characteristics. This article describes therapeutic strategies that target drug-resistance molecules and stem-cell-associated molecules as well as immunotherapy targeted at BCSCs.

KW - Cancer stem cell

KW - Glioma

KW - Immunotherapy

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=80555136553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80555136553&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:80555136553

VL - 3

SP - 48

EP - 50

JO - Open Cancer Immunology Journal

JF - Open Cancer Immunology Journal

SN - 1876-4010

ER -